Department of Medicine, Thomas Jefferson University, Philadelphia, Pa; Center for Translational Medicine; Division of Pulmonary Allergy and Critical Care Medicine, Jane and Leonard Korman Lung Center, Thomas Jefferson University, Philadelphia, Pa.
Department of Medicine, Thomas Jefferson University, Philadelphia, Pa; Center for Translational Medicine; Division of Pulmonary Allergy and Critical Care Medicine, Jane and Leonard Korman Lung Center, Thomas Jefferson University, Philadelphia, Pa.
J Allergy Clin Immunol Pract. 2023 Feb;11(2):449-457. doi: 10.1016/j.jaip.2022.10.009. Epub 2022 Oct 22.
Endogenously produced cannabinoids as well as phytocannabinoids broadly exhibit anti-inflammatory actions. Recent emergence of cannabis for multiple medical issues combined with reports on potent immunomodulatory actions of distinct components has underscored the therapeutic potential of cannabis. Although synthetic cannabinoids that are based on structural similarities to the existing class of cannabinoids have been on the rise, their application in therapeutics have been limited owing to toxicity concerns. Herein, we review the current literature that details the immunomodulatory actions of cannabinoids. Further, we highlight the complexities of cannabinoid biology and examine the potential inflammatory risks associated with the use of cannabis including potential for toxic interactions between distinct constituents of cannabis.
内源性大麻素和植物大麻素广泛表现出抗炎作用。大麻被广泛用于多种医学问题,加上对不同成分具有强大免疫调节作用的报道,突显了大麻的治疗潜力。尽管基于与现有大麻素类结构相似的合成大麻素不断增加,但由于毒性问题,它们在治疗中的应用受到限制。本文综述了大麻素的免疫调节作用的现有文献。此外,我们强调了大麻素生物学的复杂性,并研究了使用大麻相关的潜在炎症风险,包括大麻不同成分之间潜在的毒性相互作用。